209728-15-4
中文名称
3-HYDROXYPYRUVIC ACID LITHIUM SALT
英文名称
3-Hydroxypyruvic Acid Lithium Salt
CAS
209728-15-4
分子式
C3H7LiO5
分子量
130.02
MOL 文件
209728-15-4.mol
209728-15-4 结构式
基本信息
中文别名
化合物 T19364 英文别名
Hydroxypyruvic acid lithium hydrateβ-Hydroxypyruvic acid lithium hydrate
3-Hydroxypyruvic acid lithium hydrate
3-HYDROXYPYRUVIC ACID LITHIUM SALT价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2023/03/20 | HY-113013A | 3-HYDROXYPYRUVIC ACID LITHIUM SALT Hydroxypyruvic acid lithium hydrate | 209728-15-4 | 1mg | 1800元 |
| 2023/03/20 | HY-113013A | 3-HYDROXYPYRUVIC ACID LITHIUM SALT Hydroxypyruvic acid lithium hydrate | 209728-15-4 | 5mg | 5400元 |
常见问题列表
生物活性
Hydroxypyruvic acid lithium hydrate (β-Hydroxypyruvic acid lithium hydrate) 是甘氨酸、丝氨酸和苏氨酸代谢的中间产物 (intermediate)。Hydroxypyruvic acid lithium hydrate 是丝氨酸-丙酮酸氨基转移酶和乙醛酸还原酶/羟基丙酮酸还原酶的底物 (substrate)。Hydroxypyruvic acid lithium hydrate 参与了二甲基甘氨酸脱氢酶缺乏症的代谢紊乱途径。靶点
IC50: intermediate; substrate
体内研究
Hydroxypyruvic acid (lithium hydrate) (intravenous injection; 100 mg/ml; slowly over 10 min) increases the 5-h urinary oxalate and glycolate excretion to 0.68% (6.56 μmol) and 0.53% (5.10 μmol) in control rats, in addition, it increases to 2.43% (23.36 μmol) and 0.79% (7.59 μmol) of the dose in the vitamin-B6-deficient rats.